Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies.

Barbieri M, Hawkins N, Sculpher M.

Value Health. 2009 Mar-Apr;12(2):193-201. doi: 10.1111/j.1524-4733.2008.00441.x. Epub 2008 Jul 12.

2.

The use of economic evaluations in NHS decision-making: a review and empirical investigation.

Williams I, McIver S, Moore D, Bryan S.

Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175.

3.

The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.

Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N.

Health Technol Assess. 2016 Apr;20(26):1-48. doi: 10.3310/hta20260.

4.

Differences in cancer drug assessment between Spain and the United Kingdom.

Lozano-Blázquez A, Dickson R, Fraga-Fuentes MD, Martínez-Martínez F, Calleja-Hernández MÁ.

Eur J Cancer. 2015 Sep;51(13):1843-52. doi: 10.1016/j.ejca.2015.04.022. Epub 2015 Jun 25.

PMID:
26119375
5.

Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.

Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman E, Youn J.

Health Technol Assess. 2012;16(46):1-323. doi: 10.3310/hta16460.

6.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
7.

Decision making by NICE: examining the influences of evidence, process and context.

Cerri KH, Knapp M, Fernández JL.

Health Econ Policy Law. 2014 Apr;9(2):119-41. doi: 10.1017/S1744133113000030. Epub 2013 May 21. Erratum in: Health Econ Policy Law. 2014 Oct;9(4):435. Fernandez, Jose-Luis [corrected to Fernández, José-Luis].

PMID:
23688554
8.

The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.

Hettle R, Corbett M, Hinde S, Hodgson R, Jones-Diette J, Woolacott N, Palmer S.

Health Technol Assess. 2017 Feb;21(7):1-204. doi: 10.3310/hta21070.

10.

Opportunity costs and local health service spending decisions: a qualitative study from Wales.

Karlsberg Schaffer S, Sussex J, Hughes D, Devlin N.

BMC Health Serv Res. 2016 Mar 25;16:103. doi: 10.1186/s12913-016-1354-1.

11.

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.

Andronis L, Barton P, Bryan S.

Health Technol Assess. 2009 Jun;13(29):iii, ix-xi, 1-61. doi: 10.3310/hta13290. Review.

12.

Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.

Kaltenthaler E, Boland A, Carroll C, Dickson R, Fitzgerald P, Papaioannou D.

Health Technol Assess. 2011 May;15(22):1-82, iii-iv. doi: 10.3310/hta15220.

13.

The ethics of attaching research conditions to access to new health technologies.

Holland S, Hope T.

J Med Ethics. 2012 Jun;38(6):366-71. doi: 10.1136/medethics-2011-100294. Epub 2012 Feb 16.

PMID:
22345547
14.

Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.

Schmitz S, McCullagh L, Adams R, Barry M, Walsh C.

Pharmacoeconomics. 2016 Sep;34(9):925-37. doi: 10.1007/s40273-016-0406-z.

PMID:
27034245
15.

Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.

Frederix GW, Haji Ali Afzali H, Dasbach EJ, Ward RL.

Pharmacoeconomics. 2015 Aug;33(8):777-81. doi: 10.1007/s40273-015-0274-y. No abstract available.

PMID:
25827099
16.
17.

The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.

Guthrie S, Bienkowska-Gibbs T, Manville C, Pollitt A, Kirtley A, Wooding S.

Health Technol Assess. 2015 Aug;19(67):1-291. doi: 10.3310/hta19670.

18.
19.

Approaches for economic evaluations of health care technologies.

Tarride JE, Blackhouse G, Bischof M, McCarron EC, Lim M, Ferrusi IL, Xie F, Goeree R.

J Am Coll Radiol. 2009 May;6(5):307-16. doi: 10.1016/j.jacr.2009.01.011.

PMID:
19394571
20.

A thematic analysis of the strengths and weaknesses of manufacturers' submissions to the NICE Single Technology Assessment (STA) process.

Carroll C, Kaltenthaler E, FitzGerald P, Boland A, Dickson R.

Health Policy. 2011 Oct;102(2-3):136-44. doi: 10.1016/j.healthpol.2011.06.002. Epub 2011 Jul 16.

PMID:
21763025

Supplemental Content

Support Center